EUDA Health Holdings (EUDAW) Research & Development (2022)

EUDA Health Holdings (EUDAW) reported Research & Development of $7195.0 for Q2 2022, up 144.23% quarter-over-quarter from $2946.0 in Q1 2022.

EUDA Health Holdings (EUDAW) Research & Development (2022) Analysis & Trends

EUDA Health Holdings (EUDAW) has 1 years of Research & Development data on file, last reported at $7195.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 IHS Holding 45.03 Bn 44.04 Bn 231.80 -
2 Cbre 38.54 Bn 37.33 Bn 1.85 Bn -
3 Costar 14.00 Bn 12.72 Bn 701.00 Mn 114.00 Mn
4 Jones Lang Lasalle 13.85 Bn 13.53 Bn - -
5 KE Holdings 7.04 Bn 4.80 Bn 661.06 Mn -71.41 Mn
6 Compass 5.66 Bn 5.19 Bn 2.31 Bn 119.00 Mn
7 Opendoor Technologies 4.24 Bn 4.17 Bn 72.00 Mn 24.00 Mn
8 Cushman & Wakefield 3.11 Bn 2.51 Bn 420.70 Mn -
9 Newmark 2.67 Bn 2.62 Bn - -
10 EUDA Health Holdings - - - -

Historic Data

Download Data
DateValue
Jun 30, 2022 7,195.00
Mar 31, 2022 2,946.00